ES548289A0 - Procedimiento para preparar derivados de 3,4 diazol - Google Patents
Procedimiento para preparar derivados de 3,4 diazolInfo
- Publication number
- ES548289A0 ES548289A0 ES548289A ES548289A ES548289A0 ES 548289 A0 ES548289 A0 ES 548289A0 ES 548289 A ES548289 A ES 548289A ES 548289 A ES548289 A ES 548289A ES 548289 A0 ES548289 A0 ES 548289A0
- Authority
- ES
- Spain
- Prior art keywords
- diazole
- procedure
- preparing derivatives
- derivatives
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843441086 DE3441086A1 (de) | 1984-11-09 | 1984-11-09 | 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES548289A0 true ES548289A0 (es) | 1986-09-01 |
| ES8609315A1 ES8609315A1 (es) | 1986-09-01 |
Family
ID=6249961
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES548289A Expired ES8609315A1 (es) | 1984-11-09 | 1985-10-28 | Procedimiento para preparar derivados de 3,4 diazol |
| ES554601A Expired ES8704487A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3,4-diazol |
| ES554602A Expired ES8704488A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3,4-diazol |
| ES554603A Expired ES8704489A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3, 4-diazol |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES554601A Expired ES8704487A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3,4-diazol |
| ES554602A Expired ES8704488A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3,4-diazol |
| ES554603A Expired ES8704489A1 (es) | 1984-11-09 | 1986-04-30 | Procedimiento para preparar derivados de 3, 4-diazol |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4727081A (es) |
| EP (1) | EP0180754A3 (es) |
| JP (1) | JPS61115074A (es) |
| KR (1) | KR860004040A (es) |
| AU (1) | AU575441B2 (es) |
| DE (1) | DE3441086A1 (es) |
| DK (1) | DK512185A (es) |
| ES (4) | ES8609315A1 (es) |
| GR (1) | GR852687B (es) |
| HU (1) | HU194197B (es) |
| IL (1) | IL76818A (es) |
| NZ (1) | NZ214097A (es) |
| PT (1) | PT81427B (es) |
| YU (1) | YU173585A (es) |
| ZA (1) | ZA858194B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3513184A1 (de) * | 1985-04-12 | 1986-10-16 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| CN101863852B (zh) * | 2010-06-29 | 2011-09-21 | 沈阳航空航天大学 | 含1,3,4-噁二唑杂环结构芳香二元胺及其制备方法 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5775976A (en) * | 1980-08-27 | 1982-05-12 | Glaxo Group Ltd | Novel heterocyclic derivative, manufacture and medicinal composition containing same |
| JPS59196879A (ja) * | 1983-04-08 | 1984-11-08 | Wakamoto Pharmaceut Co Ltd | 新規な１，３，４−チアジアゾ−ル誘導体 |
| JPS6067474A (ja) * | 1983-09-24 | 1985-04-17 | Wakamoto Pharmaceut Co Ltd | 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤 |
| JPS60255756A (ja) * | 1984-06-01 | 1985-12-17 | Ikeda Mohandou:Kk | アミノアルキルフエノキシ誘導体 |
-
1984
- 1984-11-09 DE DE19843441086 patent/DE3441086A1/de not_active Withdrawn
-
1985
- 1985-09-25 EP EP85112139A patent/EP0180754A3/de not_active Withdrawn
- 1985-10-25 IL IL76818A patent/IL76818A/xx unknown
- 1985-10-25 ZA ZA858194A patent/ZA858194B/xx unknown
- 1985-10-28 ES ES548289A patent/ES8609315A1/es not_active Expired
- 1985-11-04 AU AU49333/85A patent/AU575441B2/en not_active Ceased
- 1985-11-04 PT PT81427A patent/PT81427B/pt unknown
- 1985-11-05 JP JP60248682A patent/JPS61115074A/ja active Pending
- 1985-11-06 DK DK512185A patent/DK512185A/da not_active Application Discontinuation
- 1985-11-06 GR GR852687A patent/GR852687B/el unknown
- 1985-11-06 NZ NZ214097A patent/NZ214097A/xx unknown
- 1985-11-06 YU YU01735/85A patent/YU173585A/xx unknown
- 1985-11-06 HU HU854271A patent/HU194197B/hu not_active IP Right Cessation
- 1985-11-07 US US06/795,992 patent/US4727081A/en not_active Expired - Fee Related
- 1985-11-07 KR KR1019850008306A patent/KR860004040A/ko not_active Application Discontinuation
-
1986
- 1986-04-30 ES ES554601A patent/ES8704487A1/es not_active Expired
- 1986-04-30 ES ES554602A patent/ES8704488A1/es not_active Expired
- 1986-04-30 ES ES554603A patent/ES8704489A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT81427A (de) | 1985-12-01 |
| IL76818A (en) | 1990-06-10 |
| ES554601A0 (es) | 1987-04-16 |
| JPS61115074A (ja) | 1986-06-02 |
| PT81427B (de) | 1987-04-09 |
| ES554602A0 (es) | 1987-04-16 |
| ES554603A0 (es) | 1987-04-16 |
| HUT40427A (en) | 1986-12-28 |
| IL76818A0 (en) | 1986-02-28 |
| DK512185A (da) | 1986-05-10 |
| EP0180754A3 (de) | 1987-02-25 |
| NZ214097A (en) | 1988-08-30 |
| ES8609315A1 (es) | 1986-09-01 |
| ZA858194B (en) | 1986-06-25 |
| DE3441086A1 (de) | 1986-05-15 |
| YU173585A (en) | 1988-04-30 |
| ES8704488A1 (es) | 1987-04-16 |
| ES8704487A1 (es) | 1987-04-16 |
| DK512185D0 (da) | 1985-11-06 |
| US4727081A (en) | 1988-02-23 |
| AU575441B2 (en) | 1988-07-28 |
| AU4933385A (en) | 1986-05-15 |
| KR860004040A (ko) | 1986-06-16 |
| ES8704489A1 (es) | 1987-04-16 |
| GR852687B (es) | 1986-03-11 |
| EP0180754A2 (de) | 1986-05-14 |
| HU194197B (en) | 1988-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX7199E (es) | Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides | |
| MX159807A (es) | Procedimiento para preparar derivados de bencimidazol | |
| AR231138A1 (es) | Procedimiento para preparar derivados de 6(7)-oxiranil-metoxi-7(6)-metoxi o oxiranil-metoxi-quinazolina | |
| ES548922A0 (es) | Procedimiento para preparar nuevos derivados de aminotetra- lina | |
| ES546484A0 (es) | Procedimiento para la preparacion de derivados de furazano | |
| ES540464A0 (es) | Procedimiento para preparar derivados de pleuromutilina | |
| ES540080A0 (es) | Procedimiento de preparar nuevos derivados de 1,3-dihidro-6-(1-hidroxi-2-dimetilaminometil-alil)-7-hidroxi-furo-(3,4-c)-piridina | |
| MX161397A (es) | Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona | |
| MX159654A (es) | Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas | |
| ES550961A0 (es) | Procedimiento para preparar derivados azolilalquilicos | |
| ES549116A0 (es) | Procedimiento para obtencion de derivados de flavolignano | |
| MX162733A (es) | Procedimiento para la preparacion de derivados amino-alcoholes | |
| ES551733A0 (es) | Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol | |
| ES530574A0 (es) | Procedimiento para preparar derivados de pirazol 1,5-a-piridina | |
| ES543985A0 (es) | Procedimiento para preparar derivados de butiramida | |
| ES555459A0 (es) | Procedimiento para preparar derivados de saframicina a. | |
| ES546908A0 (es) | Procedimiento para la preparacion de derivados de fenilace- tonitrilo | |
| ES548289A0 (es) | Procedimiento para preparar derivados de 3,4 diazol | |
| ES546802A0 (es) | Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno | |
| ES549076A0 (es) | Procedimiento para preparar derivados de fenilpiperazina | |
| ES554828A0 (es) | Procedimiento para preparar derivados de fluoralcanos. | |
| ES547090A0 (es) | Procedimiento para preparar derivados de benzazol | |
| MX156795A (es) | Procedimiento para preparar derivados de 4,5,6,7-tetrahidrofuro-(2,3-c)-piridina | |
| ES541140A0 (es) | Procedimiento para preparar derivados carboxialquildipepti- dicos | |
| AR240826A1 (es) | Procedimiento para preparar derivados de 7beta-(2-(2-aminotiazol-4-il)2-alcoxiiminoacetamido)-3-(1-piridinometil)-3-cefem-4-carboxilato |